Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gordon Joyce

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Immunity|January 16, 2021
Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadthXuejun Chen, Tongqing Zhou, Stephen D Schmidt, et al.
Immunity|February 5, 2025
Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350M Gordon Joyce, Wei Bu, Wei-Hung Chen, et al.
Plos One|July 28, 2016
Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial VirusJeffrey C Boyington, M Gordon Joyce, Mallika Sastry, et al.
Immunity|October 28, 2022
Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibitionWei-Hung Chen, JungHyun Kim, Wei Bu, et al.
Bioconjugate Chemistry|September 2, 2016
Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 AdjuvantJoseph R Francica, Geoffrey M Lynn, Richard Laga, et al.
NPJ Vaccines|April 14, 2026
Targeting the Zika virus envelope domains I and III as a recombinant vaccine protects mice from lethal challengeVincent Dussupt, Jaime L Jensen, Angélica Peña Rosado, et al.
Nature Medicine|August 25, 2015
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protectionHadi M Yassine, Jeffrey C Boyington, Patrick M McTamney, et al.
Plos Pathogens|January 12, 2017
Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral EscapeConstantinos Kurt Wibmer, Jason Gorman, Gabriel Ozorowski, et al.
Vaccines|January 21, 2023
Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in <i>E. coli</i> Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched VariantsArasu Balasubramaniyam, Emma Ryan, Dallas Brown, et al.
Cell Reports|September 3, 2020
Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent ElicitationCrystal Sao-Fong Cheung, Alexander Fruehwirth, Philipp Carl Georg Paparoditis, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Immunity|January 16, 2021
Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadthXuejun Chen, Tongqing Zhou, Stephen D Schmidt, et al.
Immunity|February 5, 2025
Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350M Gordon Joyce, Wei Bu, Wei-Hung Chen, et al.
Plos One|July 28, 2016
Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial VirusJeffrey C Boyington, M Gordon Joyce, Mallika Sastry, et al.
Immunity|October 28, 2022
Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibitionWei-Hung Chen, JungHyun Kim, Wei Bu, et al.
Bioconjugate Chemistry|September 2, 2016
Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 AdjuvantJoseph R Francica, Geoffrey M Lynn, Richard Laga, et al.
NPJ Vaccines|April 14, 2026
Targeting the Zika virus envelope domains I and III as a recombinant vaccine protects mice from lethal challengeVincent Dussupt, Jaime L Jensen, Angélica Peña Rosado, et al.
Nature Medicine|August 25, 2015
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protectionHadi M Yassine, Jeffrey C Boyington, Patrick M McTamney, et al.
Plos Pathogens|January 12, 2017
Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral EscapeConstantinos Kurt Wibmer, Jason Gorman, Gabriel Ozorowski, et al.
Vaccines|January 21, 2023
Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in <i>E. coli</i> Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched VariantsArasu Balasubramaniyam, Emma Ryan, Dallas Brown, et al.
Cell Reports|September 3, 2020
Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent ElicitationCrystal Sao-Fong Cheung, Alexander Fruehwirth, Philipp Carl Georg Paparoditis, et al.
Pageof 11